Dasatinib induces significant hematologic and cytogenetic responses in patients with imatinib-resistant or -intolerant chronic myeloid leukemia in accelerated phase.
暂无分享，去创建一个
R. Larson | M. Baccarani | J. Lipton | A. Gollerkeri | M. Talpaz | D. Heim | G. Roboz | A. Hochhaus | F. Guilhot | Dong-Wook Kim | S. Amadori | J. Apperley | C. D. de Souza | S. Branford | E. Bullorsky | P. Agarwal | M. C. Muller | Martin C Muller